Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBA-P01 vs Botox Pharmacodynamics in Healthy Men
NCT03547141Phase 1Completed
- Sponsor
- Medytox Inc.
- Start
- Apr 2018
- Primary completion
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of botulinum toxin type A in glabellar lines (4 arms), sponsored by Medytox Inc. Primary endpoint: Pharmacodynamic aspects of muscle (Compound Muscle Action Potential) at Week 12. Started Apr 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT03547141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03547141.